BioGrade · expert reasoning data for biopharma agentsEnvironmentsBenchmarkCompare modelsData flywheelThesis
← Adverse-Event Coding & Causality
Clinical / Pharmacovigilance · Drug-safety physician (PV)

Adverse-Event Coding & Causality — agent trajectory for expert review

claude-opus-4-8 · 2026-06-06T09:15:51.594769+00:00 · 4 tool calls · 21.0s · 6353 tokens
run id: ae_causality_20260606_021404_04_assess-case-icsr-005-a-patient-on-oral-fluoropyr

Query

Assess case ICSR-005 (a patient on oral fluoropyrimidine chemotherapy). Code each adverse event to MedDRA PT/SOC, determine seriousness per ICH E2A, and assign WHO-UMC causality — be explicit about which event is drug-related and which is not.

Trajectory

Agent · turn 1

I'll assess this case systematically. Let me start by pulling the case details.

⚙ calls get_case(case_id=ICSR-005)
↳ get_case result
show data
{
  "case_id": "ICSR-005",
  "study_drug": "Capecitabine",
  "drug_class": "Fluoropyrimidine chemotherapy",
  "patient": {
    "age": 67,
    "sex": "M",
    "comorbidities": [
      "metastatic colorectal cancer",
      "osteoporosis"
    ],
    "concomitant_meds": [
      "calcium/vitamin D",
      "omeprazole"
    ]
  },
  "narrative": "67-year-old man on oral fluoropyrimidine chemotherapy slipped on an icy pavement outside his home and sustained a fall, presenting to the emergency department with a closed fracture of the left femur requiring surgical fixation and a 4-day hospital stay. Separately, over the preceding two weeks he had developed a painful red rash on his palms and soles (hand-foot syndrome). The study drug was held for the hand-foot syndrome and the dose later reduced; it was unrelated to the fall.",
  "events": [
    "femur fracture from a fall",
    "painful rash on palms and soles (hand-foot syndrome)"
  ]
}
Agent · turn 2

Let me code both events and pull the drug label for fluoropyrimidine chemotherapy.

⚙ calls meddra_lookup(term=femur fracture)
⚙ calls meddra_lookup(term=hand-foot syndrome)
⚙ calls get_drug_label(drug_class=Fluoropyrimidine chemotherapy)
↳ meddra_lookup result
show data
{
  "query": "femur fracture",
  "count": 1,
  "matches": [
    {
      "pt": "Femur fracture",
      "soc": "Injury, poisoning and procedural complications",
      "synonyms": [
        "broken leg",
        "broken femur",
        "fractured femur",
        "thigh bone fracture",
        "hip fracture"
      ]
    }
  ]
}
↳ meddra_lookup result
show data
{
  "query": "hand-foot syndrome",
  "count": 1,
  "matches": [
    {
      "pt": "Palmar-plantar erythrodysaesthesia syndrome",
      "soc": "Skin and subcutaneous tissue disorders",
      "synonyms": [
        "hand-foot syndrome",
        "hand foot skin reaction",
        "ppe"
      ]
    }
  ]
}
↳ get_drug_label result
show data
{
  "drug_class": "Fluoropyrimidine chemotherapy",
  "examples": [
    "Capecitabine"
  ],
  "labeled": [
    "Palmar-plantar erythrodysaesthesia syndrome",
    "Diarrhoea",
    "Stomatitis",
    "Nausea",
    "Fatigue",
    "Hyperbilirubinaemia"
  ],
  "boxed_warning": "Increased risk of serious bleeding with concomitant warfarin (CYP interaction).",
  "note": "Hand-foot syndrome and diarrhoea are hallmark, labeled effects."
}
Agent · turn 3

Case Assessment — ICSR-005

Patient: 67-year-old male | Metastatic colorectal cancer, osteoporosis
Study drug: Capecitabine (oral fluoropyrimidine chemotherapy)
Concomitant meds: Calcium/vitamin D, omeprazole

Event 1 — Femur fracture from a fall

Field Assessment
MedDRA PT Femur fracture
SOC Injury, poisoning and procedural complications
Seriousness (ICH E2A) SERIOUS — required inpatient hospitalization (4-day stay) and surgical fixation. Meets the "requires/prolongs hospitalization" seriousness criterion.
WHO-UMC causality Unassessable / Not related (Conditional → Unlikely) with respect to the study drug. The event has a clear external mechanical cause (slip on icy pavement → trauma). There is no plausible pharmacologic pathway from capecitabine, and it is not a labeled reaction. The underlying osteoporosis is a contributing host factor for fracture, but the proximate cause is the traumatic fall.

Verdict: NOT drug-related. This is a traumatic injury. It is serious by regulatory criteria (hospitalization/surgery) but causally unrelated to capecitabine.

Note: seriousness and causality are independent axes — an event can be serious yet not drug-related, as here. It still must be captured and reported.

Event 2 — Painful red rash on palms and soles (hand-foot syndrome)

Field Assessment
MedDRA PT Palmar-plantar erythrodysaesthesia syndrome (PPE)
SOC Skin and subcutaneous tissue disorders
Seriousness (ICH E2A) NON-SERIOUS — no hospitalization, not life-threatening, not disabling/incapacitating, no death, no congenital anomaly. Managed by holding the drug and reducing the dose. (Apply medical judgment: if the reaction had become incapacitating/disabling, it could rise to serious — but as described it does not meet a criterion.)
WHO-UMC causality Probable / Likely → arguably Certain-leaning Probable. Reasoning: (1) Plausible temporal relationship — developed over the two weeks of therapy; (2) Labeled, hallmark reaction of fluoropyrimidines (PPE is a known dose-related toxicity per the drug label); (3) Positive dechallenge implied — drug held and dose reduced as management; (4) Unlikely to be explained by comorbidities or concomitant meds (calcium/vit D, omeprazole do not cause PPE). Falls short of "Certain" only because rechallenge data and precise time-course detail aren't documented.

Verdict: DRUG-RELATED. Classic, expected (labeled) toxicity of capecitabine.

Summary

Event PT (SOC) Serious? Causality Drug-related?
Fall/fracture Femur fracture (Injury, poisoning & procedural complications) Yes (hospitalization + surgery) Unlikely/Unrelated No — traumatic
Hand-foot syndrome Palmar-plantar erythrodysaesthesia syndrome (Skin & subcutaneous tissue disorders) No Probable Yes — labeled toxicity

Key teaching point: The two events dissociate the seriousness and causality axes. The serious event (fracture) is not drug-related; the drug-related event (PPE) is non-serious. Both belong in the ICSR, but neither in this case is an expedited-reportable "serious + related + unexpected" combination — the fracture is serious but unrelated, and the PPE is related but non-serious and expected (labeled). The narrative's own statement that the fall was "unrelated to the drug" is consistent with the independent pharmacologic assessment above.

Final output

Case Assessment — ICSR-005

Patient: 67-year-old male | Metastatic colorectal cancer, osteoporosis
Study drug: Capecitabine (oral fluoropyrimidine chemotherapy)
Concomitant meds: Calcium/vitamin D, omeprazole

Event 1 — Femur fracture from a fall

Field Assessment
MedDRA PT Femur fracture
SOC Injury, poisoning and procedural complications
Seriousness (ICH E2A) SERIOUS — required inpatient hospitalization (4-day stay) and surgical fixation. Meets the "requires/prolongs hospitalization" seriousness criterion.
WHO-UMC causality Unassessable / Not related (Conditional → Unlikely) with respect to the study drug. The event has a clear external mechanical cause (slip on icy pavement → trauma). There is no plausible pharmacologic pathway from capecitabine, and it is not a labeled reaction. The underlying osteoporosis is a contributing host factor for fracture, but the proximate cause is the traumatic fall.

Verdict: NOT drug-related. This is a traumatic injury. It is serious by regulatory criteria (hospitalization/surgery) but causally unrelated to capecitabine.

Note: seriousness and causality are independent axes — an event can be serious yet not drug-related, as here. It still must be captured and reported.

Event 2 — Painful red rash on palms and soles (hand-foot syndrome)

Field Assessment
MedDRA PT Palmar-plantar erythrodysaesthesia syndrome (PPE)
SOC Skin and subcutaneous tissue disorders
Seriousness (ICH E2A) NON-SERIOUS — no hospitalization, not life-threatening, not disabling/incapacitating, no death, no congenital anomaly. Managed by holding the drug and reducing the dose. (Apply medical judgment: if the reaction had become incapacitating/disabling, it could rise to serious — but as described it does not meet a criterion.)
WHO-UMC causality Probable / Likely → arguably Certain-leaning Probable. Reasoning: (1) Plausible temporal relationship — developed over the two weeks of therapy; (2) Labeled, hallmark reaction of fluoropyrimidines (PPE is a known dose-related toxicity per the drug label); (3) Positive dechallenge implied — drug held and dose reduced as management; (4) Unlikely to be explained by comorbidities or concomitant meds (calcium/vit D, omeprazole do not cause PPE). Falls short of "Certain" only because rechallenge data and precise time-course detail aren't documented.

Verdict: DRUG-RELATED. Classic, expected (labeled) toxicity of capecitabine.

Summary

Event PT (SOC) Serious? Causality Drug-related?
Fall/fracture Femur fracture (Injury, poisoning & procedural complications) Yes (hospitalization + surgery) Unlikely/Unrelated No — traumatic
Hand-foot syndrome Palmar-plantar erythrodysaesthesia syndrome (Skin & subcutaneous tissue disorders) No Probable Yes — labeled toxicity

Key teaching point: The two events dissociate the seriousness and causality axes. The serious event (fracture) is not drug-related; the drug-related event (PPE) is non-serious. Both belong in the ICSR, but neither in this case is an expedited-reportable "serious + related + unexpected" combination — the fracture is serious but unrelated, and the PPE is related but non-serious and expected (labeled). The narrative's own statement that the fall was "unrelated to the drug" is consistent with the independent pharmacologic assessment above.

Reference answer key (deterministic) — open after grading

Deterministic reference key for ICSR-005 (Capecitabine). Causality categories follow WHO-UMC; where the narrative supports more than one defensible category the rationale says so. A strong analyst recovers all events, the correct PT/SOC from the dictionary, the right seriousness criterion, and well-reasoned causality grounded in temporality, dechallenge/rechallenge, alternative etiology, and the drug label.

Event (as narrated)Expected PTExpected SOCSeriousness (ICH E2A)Causality (WHO-UMC) + rationale
femur fracture from a fallFemur fractureInjury, poisoning and procedural complicationsSerious — Hospitalization (surgical fixation, 4-day admission)Unrelated — Clear external mechanical cause (slipped on ice / traumatic fall); no pharmacologic plausibility linking the fluoropyrimidine to a traumatic fracture. Serious for reporting (hospitalization) but not drug-related.
painful rash on palms and soles (hand-foot syndrome)Palmar-plantar erythrodysaesthesia syndromeSkin and subcutaneous tissue disordersNon-serious — Does not meet a seriousness criterion (managed with dose hold/reduction)Probable — Hand-foot syndrome is a hallmark, labeled effect of fluoropyrimidines; two-week onset on therapy with positive dechallenge on dose hold/reduction.
OVERALL CASE——Serious — Hospitalization (femur fracture) — note the serious event is the unrelated trauma, not the drug reactionCase-level ICH-E2A determination

Expert grading

Event extraction completeness 1 (poor) 5 (excellent)
5: Identifies every reportable adverse event in the narrative — including a serious event that is unrelated to the drug and secondary/lab events — without lumping distinct events or inventing ones.
1: Misses reportable events (e.g. overlooks the neutropenia behind a febrile-neutropenia admission, or drops the unrelated fracture), or merges separate events into one.
MedDRA coding accuracy 1 (poor) 5 (excellent)
5: Maps each lay event to the correct Preferred Term and its System Organ Class using the dictionary lookup (e.g. 'low white count' -> Neutropenia / Blood and lymphatic system disorders; 'shortness of breath with infiltrates' -> Pneumonitis / Respiratory). PT and SOC are consistent with the dictionary, not guessed from memory.
1: Wrong PT or mismatched SOC, codes to a symptom when a diagnosis PT exists (or vice versa), or fabricates a code never returned by meddra_lookup.
Seriousness determination (ICH E2A) 1 (poor) 5 (excellent)
5: Correctly classifies each event as serious/non-serious and names the right ICH E2A criterion (death, life-threatening, hospitalization, disability, congenital anomaly, medically important) — e.g. flags the hospitalized CRS/pneumonitis/febrile-neutropenia events as serious and the asymptomatic resolved lab abnormality as non-serious.
1: Calls a clearly serious (hospitalized/life-threatening) event non-serious or vice versa, or cites the wrong/no criterion, or conflates severity grade with seriousness.
Causality assessment quality (WHO-UMC) 1 (poor) 5 (excellent)
5: Assigns a defensible WHO-UMC category with sound reasoning: weighs temporality (onset vs dosing), dechallenge/rechallenge, alternative etiologies (confounding meds, comorbidity, trauma), and whether the event is labeled — e.g. probable/certain for step-up-dose CRS, unlikely for the antibiotic-confounded transaminitis, unrelated for the traumatic fracture.
1: Reflexively blames or exonerates the drug, ignores a strong alternative etiology or the temporal mismatch, conflates seriousness with causality, or misuses the WHO-UMC categories.
Evidence faithfulness 1 (poor) 5 (excellent)
5: Grounds every PT/SOC in an actual meddra_lookup result and every causality factor in the narrative or the drug label; no invented events, codes, lab values, or label claims; states uncertainty where the narrative is genuinely ambiguous.
1: Invents events or MedDRA codes, asserts label content not returned by get_drug_label, or contradicts the narrative (wrong timing, fabricated dechallenge).
Overall verdict
Your name / ID